# Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

> **NCT01548612** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 20 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Sodium nitroprusside
- **DRUG:** Glucose solution

## Key facts

- **NCT ID:** NCT01548612
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-06
- **Final completion:** 2010-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548612, "Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01548612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*